Among these enrichments, some signaling pathways were commonly related to cisplatin resistance in osteosarcomas, such as the mitogen‐activated protein kinase (MAPK) pathway20, 21, 22, 23, 24 and vascular endothelial growth factor (VEGF).25, 26, 27. This evidence concerns the gene VEGFA and osteosarcoma.